Your browser doesn't support javascript.
loading
TPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of Schizophrenia.
Wang, Yu; He, Yang; Yang, Feipu; Abame, Melkamu Alemu; Wu, Chunhui; Peng, Yanmin; Feng, Linyin; Shen, Jingshan; Wang, Zhen; He, Ling.
Afiliación
  • Wang Y; Department of Pharmacology, China Pharmaceutical University, Nanjing, China (Y.W., L.H.); CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China (Y.W., Y.H., F.Y., M.A.A., L.F., J.S., Z.W.);
  • He Y; Department of Pharmacology, China Pharmaceutical University, Nanjing, China (Y.W., L.H.); CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China (Y.W., Y.H., F.Y., M.A.A., L.F., J.S., Z.W.);
  • Yang F; Department of Pharmacology, China Pharmaceutical University, Nanjing, China (Y.W., L.H.); CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China (Y.W., Y.H., F.Y., M.A.A., L.F., J.S., Z.W.);
  • Abame MA; Department of Pharmacology, China Pharmaceutical University, Nanjing, China (Y.W., L.H.); CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China (Y.W., Y.H., F.Y., M.A.A., L.F., J.S., Z.W.);
  • Wu C; Department of Pharmacology, China Pharmaceutical University, Nanjing, China (Y.W., L.H.); CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China (Y.W., Y.H., F.Y., M.A.A., L.F., J.S., Z.W.);
  • Peng Y; Department of Pharmacology, China Pharmaceutical University, Nanjing, China (Y.W., L.H.); CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China (Y.W., Y.H., F.Y., M.A.A., L.F., J.S., Z.W.);
  • Feng L; Department of Pharmacology, China Pharmaceutical University, Nanjing, China (Y.W., L.H.); CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China (Y.W., Y.H., F.Y., M.A.A., L.F., J.S., Z.W.);
  • Shen J; Department of Pharmacology, China Pharmaceutical University, Nanjing, China (Y.W., L.H.); CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China (Y.W., Y.H., F.Y., M.A.A., L.F., J.S., Z.W.);
  • Wang Z; Department of Pharmacology, China Pharmaceutical University, Nanjing, China (Y.W., L.H.); CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China (Y.W., Y.H., F.Y., M.A.A., L.F., J.S., Z.W.);
  • He L; Department of Pharmacology, China Pharmaceutical University, Nanjing, China (Y.W., L.H.); CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CAS), Shanghai, China (Y.W., Y.H., F.Y., M.A.A., L.F., J.S., Z.W.);
J Pharmacol Exp Ther ; 378(1): 20-30, 2021 07.
Article en En | MEDLINE | ID: mdl-33975897

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esquizofrenia / Antagonistas de la Serotonina / Antipsicóticos / Receptores de Serotonina / Receptores Dopaminérgicos / Agonistas de Receptores de Serotonina Límite: Animals / Female / Humans / Male Idioma: En Revista: J Pharmacol Exp Ther Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Esquizofrenia / Antagonistas de la Serotonina / Antipsicóticos / Receptores de Serotonina / Receptores Dopaminérgicos / Agonistas de Receptores de Serotonina Límite: Animals / Female / Humans / Male Idioma: En Revista: J Pharmacol Exp Ther Año: 2021 Tipo del documento: Article